Retina International Choroideremia Special Interest Group – RI-CHM

Retina International was approached in October by patient representatives affected by Choroideremia, who have asked if RI would consider forming a patient network. With this in mind, we have formed the Retina International Choroideremia Special Interest Group (SIG) (RI-CHM). This will be made up of volunteer patient experts who will work to connect satellite groups and organisations, as well as individuals and families affected by Choroideremia.

The group will also work to identify and connect patients affected by Choroideremia to appropriate research institutions and to established expert centres. The aim of this will be to incorporate them into the existing Choroideremia Community and provide capacity building to those who wish to engage in advocacy for their conditions. The SIG will work towards better quality of life for people living with Choroideremia through the promotion of research and equitable access to emerging therapies.

 

RI-CHM Mission:

  • To connect satellite groups and organisations as well as individuals and families affected by Choroideremia internationally.
  • To identify and connect patients affected by Choroideremia to appropriate research institutions and to established expert centres with a view to incorporating them into the existing Choroideremia and Retina Research Community.
  • To identify global ambassadors and advocates for Choroideremia in the Retina community at large.

The SIG will be chaired by Michael Längsfeld of PRO RETINA Germany and a member of the board of Directors of the Choroideremia Research Foundation. The SIG is now seeking volunteers to join and commence work on strategic planning. If you or a member of your organisation is interested in participating in this, or would like more information, please contact choroideremia@retina-international.org

 

You can find out more about Choroideremia, such as symptoms, causes and possible treatments, on our ‘Focus On Choroideremia’ section in our IRD Toolkit by clicking here.

 

European CHM Symposium Autumn 2020 Project: CHM2020

Choroideremia is a rare inherited retinal condition which is extremely lacking in currently available treatments or cures. To this end, we have decided to organise an international conference with a primary focus to communicate the realities of living with Choroideremia, inform patients of supports available and new developments in clinical research, as well as concentrate our efforts to find treatments and cures. Learn more about CHM2020 here and join us in fighting Choroideremia!

Join Our Mailing List

To keep up to date with our news and activities, please complete this simple form

Retina International
Ausstellungsstr. 36
8005 Zurich
Switzerland

Follow Us
Twitter
Youtube

This site has been supported through an unrestricted educational grant from Novartis

Novartis
Font Resize
High Contrast